The most common side effects mirror those of injectable GLP-1s nausea, mild digestive discomfort, reduced appetite, and occasional headaches, particularly in the first few weeks
Light microscopic studies
Lipolysis Enhancement and Lipogenesis Inhibition In obese Zucker rats, daily oral administration of AOD9604 significantly increased lipolytic activity in adipose tissue compared to controls, establishing direct adipocyte-level lipolysis stimulation as a key mechanism of action in pre-clinical models
A larger phase IIb trial of intranasal glutathione (300 mg/dose, three times daily for 3 months, n=45) also showed no significant improvement over placebo (Mischley et al., J Parkinsons Dis, 2017) [52]
(Mov Disord, 2009) found no significant benefit of IV glutathione (1,400 mg three times weekly for 4 weeks) over placebo [51]
P., Muchowski, P